SEARCH · Search PubMed
Results for “Lassa Fever”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Lassa fever: epidemiology, therapy and vaccine development.
Explore the source record for details and available documents.
Ribavirin therapy for lassa fever.
Explore the source record for details and available documents.
Journal of Infection Control Nursing. Nursing the isolated patient: Lassa fever.
Explore the source record for details and available documents.
[Inclusion of Lassa fever and other forms of African viral hemorrhagic fever in group A].
Explore the source record for details and available documents.
[A patient with Lassa fever from the Upper Volta, diagnosed in the Netherlands].
Explore the source record for details and available documents.
Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria.
Explore the source record for details and available documents.
Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen.
Explore the source record for details and available documents.
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.
A peripheral membrane protein that is interactive with lymphocytic choriomeningitis virus (LCMV) was purified from cells permissive to infection. Tryptic peptides from this protein were determined to be alpha-dystroglycan (alpha-DG). Several strains of LCMV and other arenaviruses, including Lassa fever virus (LFV), Oliveros, and Mobala, bound to purified alpha-DG protein. Soluble alpha-DG blocked both LCMV and LFV infection. Cells bearing a null mutation of the gene encoding DG were resistant to LCMV infection, and reconstitution of DG expression in null mutant cells restored susceptibility to LCMV infection. Thus, alpha-DG is a cellular receptor for both LCMV and LFV.
[The first imported case of Lassa fever in Japan].
Explore the source record for details and available documents.
[An evaluation of the possibility of obtaining an inactivated vaccine against Lassa fever].
Explore the source record for details and available documents.
Lassa fever, Nigeria, 2003 and 2004.
Explore the source record for details and available documents.